🇺🇸 FDA
Patent

US 8022040

Hydroxyapatite-binding peptides for bone growth and inhibition

granted A61KA61K38/00A61K9/0024

Quick answer

US patent 8022040 (Hydroxyapatite-binding peptides for bone growth and inhibition) held by The Regents of the University of California expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61K, A61K38/00, A61K9/0024, A61P, A61P19/00